Header Logo

Connection

LUKASZ SZARPAK to Purinergic P2Y Receptor Antagonists

Back to Details
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Purinergic P2Y Receptor Antagonists.
LUKASZ SZARPAK
Connection Strength
0.929
Purinergic P2Y Receptor Antagonists
  1. Efficacy and safety of ticagrelor use in pre-hospital setting. Am J Emerg Med. 2022 02; 52:265-266.
    View in: PubMed
    Score: 0.743
  2. Efficacy and safety of prasugrel and clopidogrel in st-segment elevation myocardial infarction in prehospital setting. Am J Emerg Med. 2022 03; 53:254-255.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.